During the past decade, Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica" are "Breast Cancer" (2 trials), "Triple Negative Breast Cancer" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica" in a lesser frequency.

Most popular intervention types in "Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".